176 related articles for article (PubMed ID: 31897849)
1. Neuropsychological profile of children and adolescents with psychosis risk syndrome: the CAPRIS study.
Tor J; Dolz M; Sintes-Estevez A; de la Serna E; Puig O; Muñoz-Samons D; Pardo M; Rodríguez-Pascual M; Sugranyes G; Sánchez-Gistau V; Baeza I
Eur Child Adolesc Psychiatry; 2020 Sep; 29(9):1311-1324. PubMed ID: 31897849
[TBL] [Abstract][Full Text] [Related]
2. Cognitive predictors of transition and remission of psychosis risk syndrome in a child and adolescent sample: longitudinal findings from the CAPRIS study.
Tor J; Baeza I; Sintes-Estevez A; De la Serna E; Puig O; Muñoz-Samons D; Álvarez-Subiela J; Sugranyes G; Dolz M
Eur Child Adolesc Psychiatry; 2024 Jan; 33(1):89-104. PubMed ID: 36598585
[TBL] [Abstract][Full Text] [Related]
3. Characterization of children and adolescents with psychosis risk syndrome: The Children and Adolescents Psychosis Risk Syndrome (CAPRIS) study.
Dolz M; Tor J; De la Serna E; Pardo M; Muñoz-Samons D; Rodríguez-Pascual M; Puig O; Sugranyes G; Usall J; Sánchez-Gistau V; Baeza I
Early Interv Psychiatry; 2019 Oct; 13(5):1062-1072. PubMed ID: 30478873
[TBL] [Abstract][Full Text] [Related]
4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
5. Childhood Maltreatment and Its Association with Cognitive Ability in Young People Suspected to Be at Clinical High Risk of Psychosis.
Büetiger JR; Michel C; Kaess M; Kindler J
Psychopathology; 2023; 56(1-2):17-28. PubMed ID: 35660706
[TBL] [Abstract][Full Text] [Related]
6. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
[TBL] [Abstract][Full Text] [Related]
7. Major depressive disorder and attenuated negative symptoms in a child and adolescent sample with psychosis risk syndrome: the CAPRIS study.
Rodríguez-Pascual M; Álvarez-Subiela X; Tor J; Pardo M; de la Serna E; Sugranyes G; Puig O; Baeza I; Dolz M
Eur Child Adolesc Psychiatry; 2022 Sep; 31(9):1431-1440. PubMed ID: 33893893
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive profile and onset of psychosis symptoms in children, adolescents and young adults with 22q11 deletion syndrome: A longitudinal study.
Pontillo M; Menghini D; Vicari S
Schizophr Res; 2019 Jun; 208():76-81. PubMed ID: 31056275
[TBL] [Abstract][Full Text] [Related]
9. Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis.
Eisenacher S; Rausch F; Ainser F; Englisch S; Becker A; Mier D; Fenske S; Meyer-Lindenberg A; Kirsch P; Zink M
Early Interv Psychiatry; 2018 Aug; 12(4):586-595. PubMed ID: 27169782
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence.
Woodberry KA; Seidman LJ; Giuliano AJ; Verdi MB; Cook WL; McFarlane WR
Schizophr Res; 2010 Nov; 123(2-3):188-98. PubMed ID: 20692125
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive growth charting in psychosis spectrum youths.
Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker.
Pflueger MO; Gschwandtner U; Stieglitz RD; Riecher-Rössler A
Schizophr Res; 2007 Dec; 97(1-3):14-24. PubMed ID: 17936587
[TBL] [Abstract][Full Text] [Related]
13. Course of Cognitive Development From Infancy to Early Adulthood in the Psychosis Spectrum.
Mollon J; David AS; Zammit S; Lewis G; Reichenberg A
JAMA Psychiatry; 2018 Mar; 75(3):270-279. PubMed ID: 29387877
[TBL] [Abstract][Full Text] [Related]
14. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
15. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis.
Brewer WJ; Francey SM; Wood SJ; Jackson HJ; Pantelis C; Phillips LJ; Yung AR; Anderson VA; McGorry PD
Am J Psychiatry; 2005 Jan; 162(1):71-8. PubMed ID: 15625204
[TBL] [Abstract][Full Text] [Related]
16. No sex differences in neuropsychological performance in first episode psychosis patients.
Ayesa-Arriola R; Rodriguez-Sanchez JM; Gomez-Ruiz E; Roiz-Santiáñez R; Reeves LL; Crespo-Facorro B
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():149-54. PubMed ID: 24075821
[TBL] [Abstract][Full Text] [Related]
17. Episodic memory dysfunction in individuals at high-risk of psychosis: a systematic review of neuropsychological and neurofunctional studies.
Valli I; Tognin S; Fusar-Poli P; Mechelli A
Curr Pharm Des; 2012; 18(4):443-58. PubMed ID: 22239575
[TBL] [Abstract][Full Text] [Related]
18. The relationship between psychotic-like symptoms and neurocognitive performance in a general adolescent psychiatric sample.
Lindgren M; Manninen M; Laajasalo T; Mustonen U; Kalska H; Suvisaari J; Moilanen K; Cannon TD; Huttunen M; Therman S
Schizophr Res; 2010 Oct; 123(1):77-85. PubMed ID: 20729039
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
[TBL] [Abstract][Full Text] [Related]
20. Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis.
González-Ortega I; de Los Mozos V; Echeburúa E; Mezo M; Besga A; Ruiz de Azúa S; González-Pinto A; Gutierrez M; Zorrilla I; González-Pinto A
Psychiatry Res; 2013 Mar; 206(1):8-16. PubMed ID: 22985548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
